1215374

Novartis Pharmaceuticals Corporation — FEI 2210396

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Hanover, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors